Workflow
Novo Nordisk Just Gave Investors $16.5 Billion More Reasons to Get Excited
NVONovo Nordisk(NVO) The Motley Fool·2024-02-10 14:53

Danish pharmaceutical company Novo Nordisk (NVO 2.37%) just made the headlines for something other than Ozempic. Well, sort of. One of the company's subsidiaries, Novo Holdings, is responsible for deploying capital in a mission-driven, efficient way to help broaden Novo Nordisk's reach.Earlier this week, Novo Holdings announced it was acquiring Catalent for a total enterprise value of $16.5 billion. Let's break down the deal and analyze why this transaction could be a game changer for Novo Nordisk in the lo ...